Bullisch
$358.15
Szenariopreis
$247.960
-5.976 (-2.41%)Zum Schluss
Evercore Inc. is an investment banking and investment management company. The Company's segments include Investment Banking & Equities and Investment Management. Investment Banking & Equities includes the investment banking business through which it provides advice to clients on significant mergers, acquisitions, divestitures, shareholder activism, and other strategic corporate transactions, with a particular focus on advising multinational corporations and private equity firms on large, complex transactions. It also provides liability management and restructuring advice to companies in financial transition, as well as to creditors, shareholders, and potential acquirers. Investment Management includes the wealth management business, through which it provides investment advisory, wealth management and fiduciary services for high-net-worth individuals and associated entities, and the private equity business, which holds interests in private equity funds not managed by the Company.
Evercore Inc is not a good buy right now due to its current price of $254.08, which is significantly below the lowest analyst price target of $285 from BMO Capital. The stock has a low RSI of 29.694, indicating it is oversold, but the overall trend shows a 27.67% year-to-date decline, suggesting persistent weakness. Additionally, insider activity is neutral with no significant buying or selling trends, and hedge funds are buying, but the massive downgrade in price targets reflects a lack of confidence in short-term performance. The main risk is the potential for further declines given the recent analyst downgrades and the overall market sentiment, which could lead to more volatility in the upcoming earnings report on October 28, 2026, where the EPS estimate is only 2.84, down from the last reported EPS of 2.91.
BofA
$367
2026-10-12
BofA
2026-10-12
Kursziel
$367
Morgan Stanley
$315
2026-10-08
Morgan Stanley
2026-10-08
Kursziel
$315
UBS
$318
2026-10-07
UBS
2026-10-07
Kursziel
$318
BMO Capital
$285
2026-10-06
BMO Capital
2026-10-06
Kursziel
$285
Goldman Sachs
$331
2026-10-01
Goldman Sachs
2026-10-01
Kursziel
$331
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Evercore Appoints New Co-Presidents to Strengthen Leadership

TNS Acquires netnumber to Enhance Communication Capabilities

Evercore Appoints Hans Vestberg as Senior Advisor

Evercore Appoints New Senior Managing Director

Analysis of SpaceX's Future Growth Potential
Evercore Inc. is an investment banking and investment management company. The Company's segments include Investment Banking & Equities and Investment Management. Investment Banking & Equities includes the investment banking business through which it provides advice to clients on significant mergers, acquisitions, divestitures, shareholder activism, and other strategic corporate transactions, with a particular focus on advising multinational corporations and private equity firms on large, complex transactions. It also provides liability management and restructuring advice to companies in financial transition, as well as to creditors, shareholders, and potential acquirers. Investment Management includes the wealth management business, through which it provides investment advisory, wealth management and fiduciary services for high-net-worth individuals and associated entities, and the private equity business, which holds interests in private equity funds not managed by the Company. It operates in the Financials sector (INVESTMENT ADVICE industry).
Evercore Inc is not a good buy right now due to its current price of $254.08, which is significantly below the lowest analyst price target of $285 from BMO Capital. The stock has a low RSI of 29.694, indicating it is oversold, but the overall trend shows a 27.67% year-to-date decline, suggesting persistent weakness. Additionally, insider activity is neutral with no significant buying or selling trends, and hedge funds are buying, but the massive downgrade in price targets reflects a lack of confidence in short-term performance. The main risk is the potential for further declines given the recent analyst downgrades and the overall market sentiment, which could lead to more volatility in the upcoming earnings report on October 28, 2026, where the EPS estimate is only 2.84, down from the last reported EPS of 2.91.
8 analysts cover EVR: 3 rate it Buy, 5 Hold and 0 Sell. The average price target is 389.87.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.